Author

M. R. Tooley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Walls· 1 shared A. Etemadi· 1 shared A. Roederer· 1 shared A. T. McGuire· 1 shared C. K. Harms· 1 shared D. Baker· 1 shared D. J. Campbell· 1 shared D. Veesler· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. C. Walls

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Designed proteins assemble antibodies into modular nanocages

R. Divine, H. V. Dang, G. Ueda, J. A. Fallas, I. Vulovic, W. Sheffler, S. Saini, Y. T. Zhao, I. X. Raj, P. A. Morawski, M. F. Jennewein, L. J. Homad, Y.-H. Wan, M. R. Tooley, F. Seeger, , D. Baker

The paper designs modular nanocages that assemble antibodies into precise geometries, enhancing signaling and neutralization compared to free antibodies.

bioRxiv · Dec 1, 2020Biochemistry

B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection

H. F. Moffett, C. K. Harms, K. S. Fitzpatrick, M. R. Tooley, J. Boonyaratankornkit, J. J. Taylor

This study uses CRISPR/Cas9 to engineer B cells with pathogen-specific antibodies, providing durable protection against RSV in immunocompromised hosts.

bioRxiv · Feb 6, 2019Immunology